Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China flag China · Delayed Price · Currency is CNY
19.13
-0.32 (-1.65%)
Oct 30, 2026, 3:00 PM CST

SHA:600079 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
24,44723,91825,38624,44522,27620,510
Other Revenue
43.7643.7649.3679.8461.6738.69
24,49123,96225,43524,52522,33820,549
Revenue Growth
1.31%-5.79%3.71%9.79%8.71%-0.63%
Cost of Revenue
12,36812,43514,12313,30212,63211,777
Gross Profit
12,12311,52711,31211,2239,7068,772
Selling, General & Admin
6,4846,1956,5636,1685,8275,327
Research & Development
1,5431,5011,4711,462966.86810.47
Other Operating Expenses
274.26212.6140.36202.61205.86224.56
Operating Expenses
8,3057,9568,2997,9047,0576,411
Operating Income
3,8173,5713,0143,3192,6492,361
Interest Expense
-56.55-271.04-351.37-354.14-476.57-602.15
Interest & Investment Income
759.58127.63185.18265.56978.8365.38
Currency Exchange Gain (Loss)
-30.92-30.92-23.245.96123.67-58.34
Other Non Operating Income (Expenses)
-279.44-52.11-186.88-130.81120.33-59.2
EBT Excluding Unusual Items
4,2103,3452,6373,1463,3952,007
Impairment of Goodwill
-332.06-332.06-206.98-26.15-35.33-42.68
Gain (Loss) on Sale of Investments
13.5411.8250.08136.8543.427.89
Gain (Loss) on Sale of Assets
54.6252.75-16.29-4.14-51.5126.06
Asset Writedown
-99.69-62.44-104.2-24.72-36.4-7.17
Other Unusual Items
66.7141.4362.91156.13110.86182.16
Pretax Income
3,9133,0562,4233,3843,4262,173
Income Tax Expense
659.73564644.49568.56354.75354.78
Earnings From Continuing Operations
3,2532,4921,7782,8153,0711,818
Minority Interest in Earnings
-671.76-637.12-448.6-680.78-587.19-501.05
Net Income
2,5821,8551,3302,1342,4841,317
Net Income to Common
2,5821,8551,3302,1342,4841,317
Net Income Growth
80.70%39.53%-37.70%-14.07%88.60%30.96%
Shares Outstanding (Basic)
1,6221,6271,6221,6171,6131,587
Shares Outstanding (Diluted)
1,6221,6271,6221,6291,6131,606
Shares Change
-0.79%0.36%-0.47%1.01%0.42%16.59%
EPS (Basic)
1.591.140.821.321.540.83
EPS (Diluted)
1.591.140.821.311.540.82
EPS Growth
82.14%39.02%-37.41%-14.94%87.81%12.33%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
2,1061,7861,1438.93-672.27475.78
Free Cash Flow Per Share
1.301.100.700.01-0.420.30
Dividend Per Share
0.4800.4800.4700.4600.1600.150
Dividend Growth
50.00%2.13%2.17%187.50%6.67%50.00%
Gross Margin
49.50%48.11%44.47%45.76%43.45%42.69%
Operating Margin
15.59%14.90%11.85%13.53%11.86%11.49%
Profit Margin
10.54%7.74%5.23%8.70%11.12%6.41%
Free Cash Flow Margin
8.60%7.45%4.50%0.04%-3.01%2.31%
EBITDA
4,7854,5544,0154,1083,3723,020
EBITDA Margin
19.54%19.00%15.79%16.75%15.10%14.70%
D&A For EBITDA
968.21982.641,002788.75723.08659.23
EBIT
3,8173,5713,0143,3192,6492,361
EBIT Margin
15.59%14.90%11.85%13.53%11.86%11.49%
Effective Tax Rate
16.86%18.45%26.60%16.80%10.35%16.33%
Revenue as Reported
6,07923,96225,43524,52522,33820,549